Home › Prostate Cancer › NCT03492424

Ablative Therapy in the Management of Prostate Cancer

Who can join

Ages 18 and older · Men

Inclusion Criteria:

* \>18 years of age
* Undergoing focal therapy for primary or salvage treatment of prostate cancer, or
* Have received prior focal therapy

Exclusion Criteria:

* Clinically-evident metastatic disease
* Unable to fill out an English-language questionnaire

About the study

The purpose of this study is collect observational data regarding patterns of care and outcomes of focal therapies for prostate cancer, including but not limited to: high-intensity focused ultrasound (HIFU), cryotherapy, focal laser ablation, irreversible electroporation, photodynamic therapy, and brachytherapy.

What is being tested

• cryotherapy (device)

Sponsor: Weill Medical College of Cornell University · Participants: 200 · Started: Jan 2, 2018

Contact the study team

• Holly Kuczynsk, BS · Phone: 646-962-7523

Official record on ClinicalTrials.gov — NCT03492424

Locations in the U.S.

Conditions

• Prostate Cancer

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.